|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-10-9
|
|
pubmed:abstractText |
The intramuscular use of beta interferon has been tested in the treatment of chronic hepatitis C, but it did not prove effective when the schedule was 3 million units three times a week for six months. Since the lack of effectiveness of this treatment might be due to the low bioavailability of beta interferon when administered intramuscularly, we tested a higher dosage of the drug: 6 million units three times a week for twelve months.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1125-8055
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
185-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9675656-Adult,
pubmed-meshheading:9675656-Drug Administration Schedule,
pubmed-meshheading:9675656-Female,
pubmed-meshheading:9675656-Follow-Up Studies,
pubmed-meshheading:9675656-Hepatitis C, Chronic,
pubmed-meshheading:9675656-Humans,
pubmed-meshheading:9675656-Injections, Intramuscular,
pubmed-meshheading:9675656-Interferon-beta,
pubmed-meshheading:9675656-Male,
pubmed-meshheading:9675656-Middle Aged,
pubmed-meshheading:9675656-Reference Values,
pubmed-meshheading:9675656-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Intramuscular beta interferon for chronic hepatitis C: is it worth trying?
|
|
pubmed:affiliation |
Niguarda Cà Granda Hospital, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
